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Describe role of Submitting/Presenting Trainee in this project (limit 150 words):
With aid of multidisciplinary team made a proposed consensus guideline and presented to the faculty in
NICU. After, sent out anonymous voting survey. When accepted started following infants that met criteria
for enrollment and tracked their progress. Sent just-in-time e-mail reminders to faculty and fellows.
Recorded all data and graphed results.
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Problem Statement/Question:
To develop and implement consensus guidelines with regards to initial PNS treatment for developing
BPD in high-risk infants.
Background/Project Intent (Aim Statement):
The American Academy of Pediatrics supports a selective strategy of postnatal steroid (PNS) treatment
that targets infants at high-risk for developing bronchopulmonary dysplasia (BPD). However, the lack of
evidence-based guidelines regarding optimal patient selection and timing of treatment has led to wide
variation in clinical practice.
Aim: To develop and implement consensus guidelines with regards to initial PNS treatment for
developing BPD in high-risk infants.
Methods (include PDSA cycles):
A multidisciplinary team was assembled to review evidence from existing literature as well as analyze
local data regarding PNS use for BPD. Guidelines were drafted and presented to the staff at Children’s
Mercy NICU, and consensus was reached through an anonymous voting process. The Plan-Do-Study-Act

model of quality improvement was adopted to implement the finalized guidelines. The primary outcome
measure was rate of compliance to guidelines, with a goal of ≥90% adherence by December 31, 2018.
We also looked at time to first PNS treatment, with a goal of starting treatment at 14-28 days of life.
Results:
Our consensus guidelines are presented in Figure 1. Implementation was limited to intubated infants
≤30 weeks gestation and ≤30 days of life. We adopted the Neonatal Research Network’s online BPD
outcome estimator to help identify high-risk infants for PNS treatment (Figure 2). Infants deemed highrisk by this tool were recommended for early treatment (defined as between 2-4 weeks of life) with a
short course of low-dose dexamethasone. Retrospective chart review determined a baseline rate of
compliance of 75% (n=34 over 8 month period). Following implementation of just-in-time e-mail
reminders on day of life 14, 21, and 28, a compliance rate of 92% (n=16 over 4 month period) was
achieved by December 2018 (Figure 3). Time to first PNS treatment was consistently under goal of 28
days other than two outliers (29 days and 41 days, Figure 4). In both cases there was concern for sepsis
which appropriately caused delay in steroid treatment.
Conclusions:
Just-in-time e-mail reminder system is effective in facilitating implementation of consensus guidelines
for PNS treatment, but is labor-intensive. Future aims include determining rate of mechanical ventilation
at 36 weeks postmenstrual age (clinical outcome measure) and rate of repeat or rescue PNS (balancing
measure).

Fig 2: Example of BPD outcome estimator calculation and just-in-time e-mail reminder. In this
example, the infant has a combined risk of severe BPD or death of 64.4% at 21 days of life. Per our
consensus guidelines, we would recommend him for early steroid treatment.

Figure 3: Run chart showing compliance to consensus guidelines. Baseline median rate of compliance
was 75%. After implementation of guidelines (depicted by purple vertical line) and just-in-time emails, compliance increased to a median of 92%.

Figure 4: Run chart showing time to first postnatal steroid treatment for each case in the unit that
qualifies per the guidelines. After implementation of guidelines (depicted by purple vertical line), 2
infants (case 12 and 13) received PNS treatment after the goal of 28 days. Upon chart review, these
were deemed appropriate delays in treatment due to sepsis concerns.

